Wockhardt Q4 Results: Loss widens to Rs 311 cr
indiatimes.com
economics
2022-05-30 16:30:00

AgenciesThe company said its US business was impacted by price erosion and supply disruptions with revenue in the quarter at Rs 59 crore, down from Rs 95 crore in Q4 of FY21.Pharmaceuticals firm on Monday reported widening of consolidated net loss to Rs 311 crore in the fourth quarter ended March 31, 2022. The company had posted a consolidated net loss of Rs 107 crore in the same period previous fiscal, Ltd said in a regulatory filing. Consolidated total income during the quarter under review stood at Rs 669 crore as compared to Rs 640 crore in the year-ago period, it added.
